Research Article
Oncologic Outcomes of Renal Cell Carcinoma Patients Undergoing Radical Nephrectomy and Venous Thrombectomy: Prospective Follow-Up from a Single Center
Table 1
Baseline characteristics of the study cohort (
).
| Characteristics | Value |
| Age (yr), median (IQR) | 60 (54-67) | Gender (/%) | | Male | 204 (75.6) | Female | 66 (24.4) | BMI (kg/m2), median (IQR) | 23.7 (21.3-26.0) | Laterality (/%) | | Left | 101 (37.4) | Right | 169 (62.6) | ASA level (/%) | | 1 | 15 (5.6) | 2 | 215 (79.6) | 3 | 37 (13.7) | 4 | 3 (1.1) | Symptoms (/%) | | Local | 193 (71.5) | Systemic | 77 (28.5) | Comorbidity (/%) | | Hypertension | 115 (42.6) | Coronary heart disease | 13 (4.8) | Diabetes mellitus | 30 (11.1) | Cerebrovascular disease | 5 (1.9) | Chronic lung disease | 2 (0.7) | Surgery history | 67 (24.8) | Preoperative targeted therapy (/%) | 13 (4.8) | Tumor diameter (cm) median (IQR) | 8.7 (6.6-10.5) | Preoperative SCR (μmoL/L), median (IQR) | 91 (80.8-110) | Thrombus level (/%) | | I | 67 (24.8) | II | 153 (56.6) | III | 50 (18.6) | Pulmonary embolism (/%) | 6 (2.2) | Metastasis at diagnosis (/%) | | Suspected lymph node metastasis | 169 (62.6) | Suspected adrenal metastasis | 25 (9.3) | Distant metastasis | 82 (30.4) | Lung | 56 (20.7) | Liver | 19 (7.0) | Bone | 20 (7.4) |
|
|
BMI: body mass index; ASA: American Society of Anesthesiologists; SCR: serum creatine; IQR: interquartile range.
|